cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Adicet Bio Inc
8 own
18 watching
Current Price
$1.59
$0.08
(5.3%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
243.57M
52-Week High
52-Week High
3.77000
52-Week Low
52-Week Low
1.05000
Average Volume
Average Volume
0.99M
Dividend Yield
Dividend Yield
0.04
P/E Ratio
P/E Ratio
21.7527
iconMarket Capitalization243.57M
icon52-Week High3.77000
icon52-Week Low1.05000
iconAverage Volume0.99M
iconDividend Yield0.04
iconP/E Ratio21.7527
What does the Adicet Bio Inc do?
Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors or T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and improve persistence for durable activity in patients. Its products pipeline includes ADI-001, which is in Phase 1 clinical study to treat non-Hodgkin's lymphoma; and ADI-002 that is in Phase 1 clinical study for the treatment of hepatocellular carcinoma and other solid tumors. The company is based in Boston, Massachusetts.
Read More
How much money does Adicet Bio Inc make?
News & Events about Adicet Bio Inc.
Zolmax
1 year ago
Shares of Adicet Bio, Inc. (NASDAQ:ACET Free Report) have been given a consensus recommendation of Hold by the five research firms that are covering the firm, MarketBeat.com reports. Three analysts have rated the stock with a hold rating and two have issued a buy rating on the company. The average ...
PR Newswire
1 year ago
Thinking about buying stock in Oncolytics Biotech, Nikola, American Equity Investment Life, Lordstown Motors, or Adicet Bio? Thinking about buying stock in Oncolytics Biotech, Nikola, American Equity Investment Life, Lordstown Motors, or Adicet Bio? PR Newswire NEW YORK, June 27, 2023 NEW YORK...
Ticker Report
1 year ago
Adicet Bio, Inc. (NASDAQ:ACET Get Rating) has been given a consensus recommendation of Moderate Buy by the eight ratings firms that are covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating and four have given a buy rating to...
Business Wire
1 year ago
Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer, today announced it granted inducement awards on January 31, 2023. Six individuals hired by Adicet in January 2023 received, in the aggregate...
Ticker Report
1 year ago
Shares of Adicet Bio, Inc. (NASDAQ:ACET Get Rating) have been assigned an average recommendation of Moderate Buy from the nine ratings firms that are currently covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation and ...
Frequently Asked Questions
Frequently Asked Questions
What is Adicet Bio Inc share price today?
plus_minus_icon
Can Indians buy Adicet Bio Inc shares?
plus_minus_icon
How can I buy Adicet Bio Inc shares from India?
plus_minus_icon
Can Fractional shares of Adicet Bio Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Adicet Bio Inc stocks?
plus_minus_icon
What is today’s traded volume of Adicet Bio Inc?
plus_minus_icon
What is today’s market capitalisation of Adicet Bio Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Adicet Bio Inc?
plus_minus_icon
What percentage is Adicet Bio Inc down from its 52-Week High?
plus_minus_icon
What percentage is Adicet Bio Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$1.59
$0.08
(5.3%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
Adaptimmune Therapeutics plc
Adaptimmune Therapeutics plc
$1.38
$0.08 (6.15 %)
Esperion Therapeutics, Inc.
Esperion Therapeutics, Inc.
$2.42
$-0.01 (-0.21 %)
Eagle Pharmaceuticals Inc.
Eagle Pharmaceuticals Inc.
$5.72
$-0.02 (-0.35 %)
Revance Therapeutics Inc
Revance Therapeutics Inc
$3.92
$0.15 (4.12 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
Adaptimmune Therapeutics plc
Adaptimmune Therapeutics plc
$1.38
$0.08 (6.15 %)
Esperion Therapeutics, Inc.
Esperion Therapeutics, Inc.
$2.42
$-0.01 (-0.21 %)
Eagle Pharmaceuticals Inc.
Eagle Pharmaceuticals Inc.
$5.72
$-0.02 (-0.35 %)
Revance Therapeutics Inc
Revance Therapeutics Inc
$3.92
$0.15 (4.12 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.

              Borderless Softtech Pvt Ltd ("BSPL") licenses and offers the Stockal Platform to subscribers and users who are based in India and wish to make global transactions. Such subscribers and users may be offered annual or monthly subscription plans by BSPL and in such cases, BSPL acts as their service provider.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00